Pingping Fang

Handan, 056000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Clinical, pathological, and genetic characteristics of 23 DMD patients in northern China.

Clinical, pathological, and genetic characteristics of 23 DMD patients in northern China.

Journal: Orphanet journal of rare diseases
Published: August 10, 2025

SRSF2 is upregulated in Duchenne muscular dystrophy and impairs myoblast autophagy by alternatively splicing HUWE1.

SRSF2 is upregulated in Duchenne muscular dystrophy and impairs myoblast autophagy by alternatively splicing HUWE1.

Journal: Neuromuscular disorders : NMD
Published: April 21, 2025

m6A Methylation-Induced Autophagy Impairment by TFEB Regulation in SOD1-G93A ALS Cell Model.

m6A Methylation-Induced Autophagy Impairment by TFEB Regulation in SOD1-G93A ALS Cell Model.

Journal: American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
Published: January 26, 2025

Evidence for the potential role of m6A modification in regulating autophagy in models of amyotrophic lateral sclerosis.

Evidence for the potential role of m6A modification in regulating autophagy in models of amyotrophic lateral sclerosis.

Journal: CytoJournal
Published: June 13, 2024

Research hotspots and trends for Duchenne muscular dystrophy: a machine learning bibliometric analysis from 2004 to 2023.

Research hotspots and trends for Duchenne muscular dystrophy: a machine learning bibliometric analysis from 2004 to 2023.

Journal: Frontiers in immunology
Published: May 08, 2024

Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study.

Transarterial chemoembolization plus camrelizumab is an effective and tolerable bridging therapy for patients with intermediate‑stage hepatocellular carcinoma: A pilot study.

Journal: Oncology letters
Published: March 21, 2023

Comprehensive analysis of m6A regulators characterized by the immune microenvironment in Duchenne muscular dystrophy.

Comprehensive analysis of m6A regulators characterized by the immune microenvironment in Duchenne muscular dystrophy.

Journal: Journal of translational medicine
Published: November 19, 2022

Identification of Auxiliary Biomarkers and Description of the Immune Microenvironmental Characteristics in Duchenne Muscular Dystrophy by Bioinformatical Analysis and Experiment.

Identification of Auxiliary Biomarkers and Description of the Immune Microenvironmental Characteristics in Duchenne Muscular Dystrophy by Bioinformatical Analysis and Experiment.

Journal: Frontiers in neuroscience
Published: March 08, 2022

The clinical value of long noncoding RNA GAS5 in acute ischemic stroke: Correlation with disease risk, inflammation, severity, and risk of recurrence.

The clinical value of long noncoding RNA GAS5 in acute ischemic stroke: Correlation with disease risk, inflammation, severity, and risk of recurrence.

Journal: Journal of clinical laboratory analysis
Published: August 31, 2021

MicroRNA-362-3p Targets PAX3 to Inhibit the Development of Glioma through Mediating Wnt/β-Catenin Pathway.

MicroRNA-362-3p Targets PAX3 to Inhibit the Development of Glioma through Mediating Wnt/β-Catenin Pathway.

Journal: Neuroimmunomodulation
Published: February 28, 2019

Circulating high mobility group box-1 and toll-like receptor 4 expressions increase the risk and severity of epilepsy.

Circulating high mobility group box-1 and toll-like receptor 4 expressions increase the risk and severity of epilepsy.

Journal: Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica
Published: October 21, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026